Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2026.
Financial Results
Revenue
The revenues for the second quarter of fiscal 2026 were $7.8 million compared to $7.9 million for the second quarter of fiscal 2025, a 2% decrease. The revenues for the second quarter of fiscal 2026 consisted of $7.71 million in processing and storage fee revenue, $46,000 in public banking revenue and $14,000 in product revenue compared to $7.87 million in processing and storage fee revenue, $43,000 in public banking revenue and $14,000 in product revenue for the second quarter of fiscal 2025.
